Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat


Tytuł :
Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy.
Autorzy :
Shi S; Diabetes Center, Zhejiang Provincial Key Laboratory of Pathophysiology, Institute of Biochemistry and Molecular Biology, School of Medicine, Ningbo University, Ningbo, China.
Ma T; Diabetes Center, Zhejiang Provincial Key Laboratory of Pathophysiology, Institute of Biochemistry and Molecular Biology, School of Medicine, Ningbo University, Ningbo, China.
Xi Y; Diabetes Center, Zhejiang Provincial Key Laboratory of Pathophysiology, Institute of Biochemistry and Molecular Biology, School of Medicine, Ningbo University, Ningbo, China. Electronic address: .
Pokaż więcej
Źródło :
Archives of biochemistry and biophysics [Arch Biochem Biophys] 2021 Sep 15; Vol. 708, pp. 108950. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy*
Urinary Bladder Neoplasms/*immunology
Urinary Bladder Neoplasms/*therapy
Gene Expression Regulation, Neoplastic ; Humans ; Prognosis ; Tumor Microenvironment/immunology ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/genetics
Czasopismo naukowe
Tytuł :
The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study.
Autorzy :
Metwally MI; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Zeed NA; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Hamed EM; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Elshetry ASF; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Elfwakhry RM; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Alaa Eldin AM; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Sakr A; Department of Urology, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Aly SA; Department of Radio-diagnosis, Faculty of Human Medicine, Benha University, Benha, Egypt.
Mosallam W; Department of Radio-diagnosis, Faculty of Human Medicine, Suez Canal University, Ismailia, Egypt.
Ziada YMA; Department of Radio-diagnosis, Al-Ahrar Teaching Hospital, Zagazig, Egypt.
Balata R; Department of Clinical Oncology, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Harb OA; Department of Pathology, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
Basha MAA; Department of Radio-diagnosis, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Sep; Vol. 31 (9), pp. 6949-6961. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/surgery
Cystectomy ; Humans ; Magnetic Resonance Imaging ; Muscles ; Prospective Studies ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
Autorzy :
Sharma V; Department of Urology, Mayo Clinic, Rochester, Minnesota.; Department of Urology, University of California, Los Angeles, California.; Greater Los Angeles VA, Health Services Research and Development Program, Los Angeles, California.
Miest TS; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
Juvet TS; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Toussi A; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Packiam V; Department of Urology, University of Iowa Medical Center, Iowa City, Iowa.
Chamie K; Department of Urology, University of California, Los Angeles, California.
Matin SF; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Thompson RH; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Frank I; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Tollefson MK; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Potretzke AM; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 558-567. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Carcinoma, Transitional Cell/*epidemiology
Kidney Neoplasms/*surgery
Nephroureterectomy/*adverse effects
Ureteral Neoplasms/*surgery
Urinary Bladder Neoplasms/*epidemiology
Aged ; Biopsy/adverse effects ; Biopsy/methods ; Biopsy/statistics & numerical data ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/secondary ; Carcinoma, Transitional Cell/surgery ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/pathology ; Male ; Neoplasm Seeding ; Proportional Hazards Models ; Retrospective Studies ; Ureteral Neoplasms/diagnosis ; Ureteral Neoplasms/pathology ; Ureteroscopy/adverse effects ; Ureteroscopy/statistics & numerical data ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/secondary
Czasopismo naukowe
Tytuł :
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
Autorzy :
Katims AB; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Say R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Derweesh I; Department of Urology, University of California San Diego School of Medicine, La Jolla, California.
Uzzo R; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Minervini A; Department of Urology, University of Florence, Florence, Italy.
Wu Z; Department of Urology, Changzheng Hospital, Second Military (Naval) Medical University, Shanghai, China.
Abdollah F; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Sundaram C; Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana.
Ferro M; Division of Urology, European Institute of Oncology, Milan, Italy.
Rha K; Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Mottrie A; Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
Rosiello G; Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
Simone G; Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
Eun DD; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Reese A; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Kidd LC; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Porter J; Swedish Urology Group, Seattle, Washington.
Bhattu AS; Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Gonzalgo ML; Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
Marcus J; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Danno A; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Meagher M; Department of Urology, University of California San Diego School of Medicine, La Jolla, California.
Tellini R; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Mari A; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Veccia A; Division of Urology, VCU Health System, Richmond, Virginia.
Ghoreifi A; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Autorino R; Division of Urology, VCU Health System, Richmond, Virginia.
Djaladat H; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 568-576. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Carcinoma, Transitional Cell/*epidemiology
Kidney Neoplasms/*surgery
Nephroureterectomy/*adverse effects
Robotic Surgical Procedures/*adverse effects
Ureteral Neoplasms/*surgery
Urinary Bladder Neoplasms/*epidemiology
Aged ; Biopsy/adverse effects ; Biopsy/methods ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/secondary ; Carcinoma, Transitional Cell/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/mortality ; Male ; Margins of Excision ; Middle Aged ; Neoplasm Seeding ; Nephroureterectomy/methods ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Ureter/pathology ; Ureter/surgery ; Ureteral Neoplasms/diagnosis ; Ureteral Neoplasms/mortality ; Ureteroscopy/adverse effects ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/secondary
Czasopismo naukowe
Tytuł :
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
Autorzy :
Petros FG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Department of Urology, The University of Toledo Medical Center, Toledo, Ohio.
Choi W; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, Maryland.
Qi Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moss T; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Viracor Eurofins Clinical Diagnostics, Lee's Summit, Missouri.
Li R; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Department of Urology, Moffitt Cancer Center, Tampa, Florida.
Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Czerniak B; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Dinney C; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
McConkey DJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, Maryland.
Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 548-557. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Transitional Cell/*diagnosis
Kidney Neoplasms/*diagnosis
Neoplasms, Multiple Primary/*diagnosis
Neoplasms, Second Primary/*diagnosis
Ureteral Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*diagnosis
Aged ; Biomarkers, Tumor/genetics ; Carcinoma, Transitional Cell/genetics ; Carcinoma, Transitional Cell/immunology ; Carcinoma, Transitional Cell/surgery ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Kidney/immunology ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/genetics ; Kidney Neoplasms/immunology ; Kidney Neoplasms/surgery ; Male ; Neoplasms, Multiple Primary/genetics ; Neoplasms, Multiple Primary/immunology ; Neoplasms, Multiple Primary/surgery ; Neoplasms, Second Primary/genetics ; Neoplasms, Second Primary/immunology ; Neoplasms, Second Primary/surgery ; RNA-Seq ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Ureter/immunology ; Ureter/pathology ; Ureter/surgery ; Ureteral Neoplasms/genetics ; Ureteral Neoplasms/immunology ; Ureteral Neoplasms/surgery ; Urinary Bladder/immunology ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/immunology ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł :
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
Autorzy :
Burns JE; Leeds Institute of Medical Research, St. James' University Hospital, University of Leeds, Leeds, UK.
Hurst CD; Leeds Institute of Medical Research, St. James' University Hospital, University of Leeds, Leeds, UK.
Knowles MA; Leeds Institute of Medical Research, St. James' University Hospital, University of Leeds, Leeds, UK.
Phillips RM; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Allison SJ; Leeds Institute of Medical Research, St. James' University Hospital, University of Leeds, Leeds, UK.; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Sep; Vol. 112 (9), pp. 3822-3834. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article
MeSH Terms :
Transcriptome*
Warburg Effect, Oncologic*/drug effects
L-Lactate Dehydrogenase/*metabolism
Lactic Acid/*biosynthesis
Urinary Bladder Neoplasms/*genetics
Urinary Bladder Neoplasms/*metabolism
Apoptosis/genetics ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/genetics ; Gene Knockdown Techniques ; Humans ; Isoenzymes/genetics ; Isoenzymes/metabolism ; L-Lactate Dehydrogenase/genetics ; Molecular Targeted Therapy/methods ; Neoplasm Staging ; RNA Interference ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Transfection ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette-Guérin.
Autorzy :
Kim JH; Department of Urology, Hanil General Hospital, 308 Uicheon-ro, Dobong-gu, Seoul 01450, Korea.
Lee S; School of Mechanical Engineering, College of Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Kang SJ; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Choi YW; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Choi SY; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Park JY; School of Mechanical Engineering, College of Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.; Department of Intelligent Energy and Industry, Graduate School, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Chang IH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 18; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Movement*
Cell Proliferation*
BCG Vaccine/*administration & dosage
Bioprinting/*instrumentation
Cytokines/*metabolism
Lab-On-A-Chip Devices/*statistics & numerical data
Urinary Bladder Neoplasms/*drug therapy
Bioprinting/methods ; Humans ; Tumor Cells, Cultured ; Urinary Bladder Neoplasms/immunology ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma.
Autorzy :
Luo HL; Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Liu HY; Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Chang YL; Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Sung MT; Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Chen PY; Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Su YL; Department of Hematology and Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Huang CC; Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Peng JM; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 16; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article
MeSH Terms :
DNA Methylation*
Drug Resistance, Neoplasm*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carrier Proteins/*metabolism
Urinary Bladder Neoplasms/*drug therapy
Urinary Bladder Neoplasms/*pathology
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Carrier Proteins/genetics ; Cell Proliferation ; Gene Expression Profiling ; Humans ; Mice ; Prognosis ; Survival Rate ; Tumor Cells, Cultured ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
[Osteoclast-Like giant cell bladder carcinoma: Case report].
Autorzy :
Amaya-Fragoso E; Instituto Mexicano del Seguro Social, Centro Médico Nacional del Noreste, Hospital de Especialidades No. 25, Departamento de Urología. Monterrey, Nuevo León, México.
Dantés-Duran MA; Instituto Mexicano del Seguro Social, Centro Médico Nacional del Noreste, Hospital de Especialidades No. 25, Departamento de Patología. Monterrey, Nuevo León, México.
Pérez-Torres EK; Instituto Mexicano del Seguro Social, Centro Médico Nacional del Noreste, Hospital de Especialidades No. 25, Departamento de Patología. Monterrey, Nuevo León, México.
García-Pérez CM; Instituto Mexicano del Seguro Social, Centro Médico Nacional del Noreste, Hospital de Especialidades No. 25, Departamento de Urología. Monterrey, Nuevo León, México.
Pokaż więcej
Transliterated Title :
Carcinoma de vejiga de células gigantes parecidas a osteoclasto: reporte de caso.
Źródło :
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2021 Aug 13; Vol. 59 (3), pp. 253-259. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/surgery
Aged ; Giant Cells ; Humans ; Male ; Osteoclasts
Czasopismo naukowe
Tytuł :
The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada.
Autorzy :
Wissing MD; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada; Department of Oncology, McGill University, Montreal, QC, Canada. Electronic address: .
O'Flaherty A; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
Dragomir A; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
Tanguay S; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
Kassouf W; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
Aprikian AG; Department of Surgery, McGill University Health Centre, Montreal, QC, Canada; Department of Oncology, McGill University, Montreal, QC, Canada.
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2021 Aug; Vol. 19 (4), pp. 371-371.e9. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystectomy*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
5-alpha Reductase Inhibitors ; Humans ; Male ; Quebec ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Occupational cancers in urology].
Autorzy :
Golka K; Leibniz-Institut für Arbeitsforschung an der TU Dortmund (IfADo), Ardeystr. 67, 44139, Dortmund, Deutschland. .
Böthig R; Abteilung Neuro-Urologie, BG Klinikum Hamburg, Hamburg, Deutschland.
Jungmann O; Urologische Klinik Lindenthal, Malteser Krankenhaus St. Hildegardis, Köln, Deutschland.
Forchert M; Stabsstelle UV-Recht, Berufsgenossenschaft Holz und Metall, Bielefeld, Deutschland.
Zellner ME; Abteilung Urologie und Neurourologie, Johannesbad Fachklinik, Bad Füssing, Deutschland.
Schöps W; Sankt Augustin, Deutschland.
Pokaż więcej
Transliterated Title :
Berufsbedingte Krebserkrankungen in der Urologie.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2021 Aug; Vol. 60 (8), pp. 1061-1072. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney Neoplasms*
Occupational Diseases*/diagnosis
Occupational Diseases*/epidemiology
Occupational Diseases*/etiology
Occupational Exposure*/adverse effects
Urinary Bladder Neoplasms*/chemically induced
Urinary Bladder Neoplasms*/epidemiology
Urology*
Humans ; Male
Czasopismo naukowe
Tytuł :
Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View.
Autorzy :
Kim HJ; Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, Korea.
Chun J; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim TH; Department of Radiation Oncology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Yang G; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Shin SJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim JS; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Yang J; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
Ham WS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea. .
Koom WS; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Yonsei medical journal [Yonsei Med J] 2021 Jul; Vol. 62 (7), pp. 569-576.
Typ publikacji :
Journal Article
MeSH Terms :
Cystectomy*
Urinary Bladder Neoplasms*/radiotherapy
Urinary Bladder Neoplasms*/surgery
Humans ; Neoplasm Recurrence, Local/epidemiology ; Radiation Oncologists ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients.
Autorzy :
Au D; Department of Urology, University of Kansas Health System, Kansas City, KS, United States.
Lee EK; Department of Urology, University of Kansas Health System, Kansas City, KS, United States.
Popoola TO; Department of Population, Health University of Kansas Health System, Kansas City, KS, United States.
Parker WP; Department of Urology, University of Kansas Health System, Kansas City, KS, United States.
Onge JMS; Department of Population, Health University of Kansas Health System, Kansas City, KS, United States.
Ellis SD; Department of Population, Health University of Kansas Health System, Kansas City, KS, United States.
Pokaż więcej
Źródło :
International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2021 Jul-Aug; Vol. 47 (4), pp. 803-818.
Typ publikacji :
Journal Article
MeSH Terms :
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Adult ; Aged ; Comorbidity ; Cystectomy ; Female ; Humans ; Middle Aged ; Muscles ; Neoadjuvant Therapy ; Neoplasm Invasiveness ; Retrospective Studies ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
Autorzy :
Yamashita S; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Iguchi T; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Koike H; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Wakamiya T; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Kikkawa K; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Kohjimoto Y; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Hara I; Department of Urology, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 Jul; Vol. 28 (7), pp. 757-762. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Sarcopenia*/complications
Sarcopenia*/diagnostic imaging
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Aged ; Cystectomy/adverse effects ; Female ; Humans ; Muscle, Skeletal/diagnostic imaging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy.
Autorzy :
Lou Y; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Ma C; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Liu Z; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Shi J; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Zheng G; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Zhang C; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Zhang Z; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: .
Pokaż więcej
Źródło :
Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2021 Sep 15; Vol. 221, pp. 112420. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article
MeSH Terms :
Urinary Bladder Neoplasms*/blood
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/pathology
Antimony/*toxicity
Environmental Pollutants/*toxicity
Protein Kinases/*metabolism
Ubiquitin-Protein Ligases/*metabolism
Animals ; Antimony/blood ; Cell Line, Tumor ; Environmental Pollutants/blood ; Humans ; Membrane Potential, Mitochondrial/drug effects ; Mice, Inbred BALB C ; Mice, Nude ; Mitophagy/drug effects
Czasopismo naukowe
Tytuł :
Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.
Autorzy :
Liao CH; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.; National Defense Medical Center, Taipei, Taiwan, R.O.C.
Tsai CW; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Chang WS; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Wang ZH; Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
Gong CL; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Wu HC; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Wang BR; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.; National Defense Medical Center, Taipei, Taiwan, R.O.C.
Hsu SW; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.; National Defense Medical Center, Taipei, Taiwan, R.O.C.
Huang WC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Shen TC; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Bau DT; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; .; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.; Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
Pokaż więcej
Źródło :
In vivo (Athens, Greece) [In Vivo] 2021 Sep-Oct; Vol. 35 (5), pp. 2535-2540.
Typ publikacji :
Journal Article
MeSH Terms :
Matrix Metalloproteinase 1*/genetics
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/genetics
Case-Control Studies ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single Nucleotide ; Risk Factors
Czasopismo naukowe
Tytuł :
The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
Autorzy :
Erkoc M; Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Otunctemur A; Department of Urology, Prof. Dr Cemil Tascioglu City Hospital, Istanbul, Turkey.
Bozkurt M; Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Can O; Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Atalay HA; Department of Urology, Beylikduzu State Hospital, Istanbul, Turkey.
Besiroglu H; Department of Urology, Istanbul-Cerrahpasa University Faculty of Medicine, Istanbul, Turkey.
Danis E; Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Degirmentepe RB; Department of Urology, Of State Hospital, Trabzon, Turkey.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Sep; Vol. 75 (9), pp. e14584. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/surgery
Humans ; ROC Curve ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Autorzy :
Goyal A; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
O'Leary D; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Goyal K; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
Rubin N; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Janakiram M; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Sep; Vol. 35 (9), pp. 1821-1829. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Hodgkin Disease*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/epidemiology
Lymphoma, Non-Hodgkin*/complications
Lymphoma, Non-Hodgkin*/diagnosis
Lymphoma, Non-Hodgkin*/epidemiology
Melanoma*/complications
Melanoma*/diagnosis
Melanoma*/epidemiology
Mycosis Fungoides*/complications
Mycosis Fungoides*/diagnosis
Mycosis Fungoides*/epidemiology
Neoplasms, Second Primary*/diagnosis
Neoplasms, Second Primary*/epidemiology
Skin Neoplasms*/complications
Skin Neoplasms*/diagnosis
Skin Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/epidemiology
Aged ; Early Detection of Cancer ; Female ; Humans ; Lung ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
[BCG-induced (bacillus Calmette-Guérin) abdominal granulomatosis after occult bladder perforation].
Autorzy :
Lawaczeck L; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland. .
Fischer AK; Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.
Norz V; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Rausch S; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Bedke J; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Stenzl A; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Amend B; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Pokaż więcej
Transliterated Title :
Intraabdominelle BCG-Granulomatose (Bacillus Calmette-Guérin) nach okkulter Blasenperforation.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2021 Sep; Vol. 60 (9), pp. 1184-1187. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Urinary Bladder Diseases*/chemically induced
Urinary Bladder Diseases*/diagnosis
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Administration, Intravesical ; BCG Vaccine/adverse effects ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.
Autorzy :
Murakami K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kita Y; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sakatani T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hamada A; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mizuno K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Nakamura K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takada H; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Matsumoto K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sano T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Goto T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akamatsu S; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Saito R; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tsuruyama T; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ogawa O; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Sep; Vol. 112 (9), pp. 3669-3681. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Cell Cycle Proteins/*antagonists & inhibitors
Cisplatin/*administration & dosage
Enzyme Inhibitors/*administration & dosage
Protein-Tyrosine Kinases/*antagonists & inhibitors
Pyrazoles/*administration & dosage
Pyrimidinones/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Animals ; Apoptosis/drug effects ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Drug Synergism ; Drug Therapy, Combination ; Female ; Gene Knockdown Techniques ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Mice, SCID ; Mitosis/drug effects ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Transfection ; Treatment Outcome ; Tumor Suppressor Protein p53/deficiency ; Tumor Suppressor Protein p53/genetics ; Urinary Bladder Neoplasms/metabolism ; Urinary Bladder Neoplasms/pathology ; Xenograft Model Antitumor Assays
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies